Over the past year, so-called "spread pricing" has generated controversy over allegations that pharmacy benefit managers pocket portions of payments that should go to state programs. CMS is trying to mitigate that with new guidance. In other pharmaceutical news: a false advertising lawsuit, a dispute over immunotherapy, a health-tracking forum, and more.

from Kaiser Health News http://bit.ly/2VF8YDy

Related Posts:

0 comments:

Post a Comment

Popular Posts